Neural computing in cancer drug development: predicting mechanism of action.

Described here are neural networks capable of predicting a drug's mechanism of action from its pattern of activity against a panel of 60 malignant cell lines in the National Cancer Institute's drug screening program. Given six possible classes of mechanism, the network misses the correct category for only 12 out of 141 agents (8.5 percent), whereas linear discriminant analysis, a standard statistical technique, misses 20 out of 141 (14.2 percent). The success of the neural net indicates several things. (i) The cell line response patterns are rich in information about mechanism. (ii) Appropriately designed neural networks can make effective use of that information. (iii) Trained networks can be used to classify prospectively the more than 10,000 agents per year tested by the screening program. Related networks, in combination with classical statistical tools, will help in a variety of ways to move new anticancer agents through the pipeline from in vitro studies to clinical application.

[1]  K D Paull,et al.  Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. , 1992, Biochemical and biophysical research communications.

[2]  S. Knudsen,et al.  Neural network detects errors in the assignment of mRNA splice sites. , 1990, Nucleic acids research.

[3]  D A Scudiero,et al.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.

[4]  Malcolm J. McGregor,et al.  Prediction of β-turns in proteins using neural networks , 1989 .

[5]  Q. Mcnemar.  Note on the sampling error of the difference between correlated proportions or percentages , 1947, Psychometrika.

[6]  J M Boone,et al.  Neural networks in radiology: an introduction and evaluation in a signal detection task. , 1990, Medical physics.

[7]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[8]  K D Paull,et al.  Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. , 1992, Cancer research.

[9]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[10]  D. Scudiero,et al.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. , 1988, Cancer research.

[11]  P Sherman,et al.  Classification of ultrasonic image texture by statistical discriminant analysis of neutral networks. , 1991, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[12]  M. Karplus,et al.  Protein secondary structure prediction with a neural network. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M M Mesulam,et al.  Large‐scale neurocognitive networks and distributed processing for attention, language, and memory , 1990, Annals of neurology.

[14]  Harold H. Szu,et al.  Neural networks based on peano curves and hairy neurons , 1990 .

[15]  Y. Wu,et al.  Potential usefulness of an artificial neural network for differential diagnosis of interstitial lung diseases: pilot study. , 1990, Radiology.

[16]  G. Zhou,et al.  Neural network optimization for E. coli promoter prediction. , 1991, Nucleic acids research.

[17]  K D Paull,et al.  Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. , 1991, The Journal of biological chemistry.

[18]  M. O'Neill,et al.  Training back-propagation neural networks to define and detect DNA-binding sites. , 1991, Nucleic acids research.

[19]  R Langridge,et al.  Improvements in protein secondary structure prediction by an enhanced neural network. , 1990, Journal of molecular biology.

[20]  Geoffrey E. Hinton,et al.  Learning representations by back-propagating errors , 1986, Nature.